TC-N19, a novel dual inhibitor of EGFR and cMET, efficiently overcomes EGFR-TKI resistance in non-small-cell lung cancer cells
2016 ◽
Vol 7
(6)
◽
pp. e2290-e2290
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 9
(6)
◽
pp. 2417-2422
◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 113
(3)
◽
pp. 141-142
◽
Keyword(s):
2018 ◽
Vol 11
◽
pp. 455-467
◽
Keyword(s):
2015 ◽
Vol 16
(4)
◽
pp. 549-557
◽
Keyword(s):